Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million

The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery. The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery. Read the full story on NYT Business via the link below.